365 related articles for article (PubMed ID: 20851939)
1. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Park SH; Moon WK; Cho N; Song IC; Chang JM; Park IA; Han W; Noh DY
Radiology; 2010 Oct; 257(1):56-63. PubMed ID: 20851939
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.
Iima M; Le Bihan D; Okumura R; Okada T; Fujimoto K; Kanao S; Tanaka S; Fujimoto M; Sakashita H; Togashi K
Radiology; 2011 Aug; 260(2):364-72. PubMed ID: 21633054
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.
Ei Khouli RH; Jacobs MA; Mezban SD; Huang P; Kamel IR; Macura KJ; Bluemke DA
Radiology; 2010 Jul; 256(1):64-73. PubMed ID: 20574085
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma.
Zhang GY; Wang YJ; Liu JP; Zhou XH; Xu ZF; Chen XP; Xu T; Wei WH; Zhang Y; Huang Y
Biomed Res Int; 2015; 2015():307943. PubMed ID: 26413513
[TBL] [Abstract][Full Text] [Related]
7. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings.
Woodhams R; Kakita S; Hata H; Iwabuchi K; Kuranami M; Gautam S; Hatabu H; Kan S; Mountford C
Radiology; 2010 Feb; 254(2):357-66. PubMed ID: 20093508
[TBL] [Abstract][Full Text] [Related]
8. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.
Kim SH; Lee JM; Hong SH; Kim GH; Lee JY; Han JK; Choi BI
Radiology; 2009 Oct; 253(1):116-25. PubMed ID: 19789256
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response.
Santamaría G; Bargalló X; Fernández PL; Farrús B; Caparrós X; Velasco M
Radiology; 2017 Jun; 283(3):663-672. PubMed ID: 27875106
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the treatment response to neoadjuvant chemotherapy in locally advanced breast cancer using combined magnetic resonance vascular maps and apparent diffusion coefficient.
Wu LA; Chang RF; Huang CS; Lu YS; Chen HH; Chen JY; Chang YC
J Magn Reson Imaging; 2015 Nov; 42(5):1407-20. PubMed ID: 25875904
[TBL] [Abstract][Full Text] [Related]
11. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.
Bufi E; Belli P; Costantini M; Cipriani A; Di Matteo M; Bonatesta A; Franceschini G; Terribile D; Mulé A; Nardone L; Bonomo L
Clin Breast Cancer; 2015 Oct; 15(5):370-80. PubMed ID: 25891905
[TBL] [Abstract][Full Text] [Related]
12. Value of Dynamic Contrast-enhanced and Diffusion-weighted MR Imaging in the Detection of Pathologic Complete Response in Cervical Cancer after Neoadjuvant Therapy: A Retrospective Observational Study.
Jalaguier-Coudray A; Villard-Mahjoub R; Delouche A; Delarbre B; Lambaudie E; Houvenaeghel G; Minsat M; Tallet A; Sabatier R; Thomassin-Naggara I
Radiology; 2017 Aug; 284(2):432-442. PubMed ID: 28301309
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Assessment of Rectal Cancer Response to Neoadjuvant Combined Chemotherapy and Radiation Therapy: Comparison of Three Methods of Positioning Region of Interest for ADC Measurements at Diffusion-weighted MR Imaging.
Blazic IM; Lilic GB; Gajic MM
Radiology; 2017 Feb; 282(2):418-428. PubMed ID: 27253423
[TBL] [Abstract][Full Text] [Related]
15. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?
Donati OF; Jung SI; Vargas HA; Gultekin DH; Zheng J; Moskowitz CS; Hricak H; Zelefsky MJ; Akin O
Radiology; 2013 Aug; 268(2):440-50. PubMed ID: 23481164
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer.
Surov A; Wienke A; Meyer HJ
Breast; 2020 Oct; 53():59-67. PubMed ID: 32652460
[TBL] [Abstract][Full Text] [Related]
19. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.
Kim S; Jain M; Harris AB; Lee VS; Babb JS; Sigmund EE; Rueff LE; Taouli B
Radiology; 2009 Jun; 251(3):796-807. PubMed ID: 19380690
[TBL] [Abstract][Full Text] [Related]
20. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.
Parikh T; Drew SJ; Lee VS; Wong S; Hecht EM; Babb JS; Taouli B
Radiology; 2008 Mar; 246(3):812-22. PubMed ID: 18223123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
